Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (351-360 of 651) with videos related to

Pageof 66
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2010
Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cellsSergey V Novitskiy, Ildiko Csiki, Yuhui Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometryJoseph M Amann, Pierre Chaurand, Adriana Gonzalez, et al.
Minerva Chirurgica|February 28, 1987
[Ultrasonics in the study of latero-cervical metastasis of head and neck tumors]G Margarino, L Derchi, G Amoretti, et al.
JTO Clinical and Research Reports|April 20, 2026
Cost-Effectiveness of Perioperative Immune Checkpoint Therapy for NSCLC in Japan, the United States, and BrazilMasahiro Fujioka, Toshihiko Aranishi, Takehito Shukuya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2020
Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLCTakehito Shukuya, Vikas Ghai, Joseph M Amann, et al.
Clinical Lung Cancer|July 10, 2018
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung CancerAshwini Arunachalam, Haojie Li, Marisa A Bittoni, et al.
European Journal of Cancer|January 1, 1977
Phase I-II trial of intramuscularly administered bleomycinM H Cohen, S J Pocock, E D Savlov, et al.
Journal of the National Cancer Institute|December 15, 1993
Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survivalS F Winter, Y Sekido, J D Minna, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2019
The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung CancerTakehito Shukuya, Tadaaki Yamada, Michael J Koenig, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2018
Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLCSara L Sinicropi-Yao, Joseph M Amann, David Lopez Y Lopez, et al.
Pageof 66

Showing results (351-360 of 651) with videos related to

Sort By:
Pageof 66
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2010
Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cellsSergey V Novitskiy, Ildiko Csiki, Yuhui Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometryJoseph M Amann, Pierre Chaurand, Adriana Gonzalez, et al.
Minerva Chirurgica|February 28, 1987
[Ultrasonics in the study of latero-cervical metastasis of head and neck tumors]G Margarino, L Derchi, G Amoretti, et al.
JTO Clinical and Research Reports|April 20, 2026
Cost-Effectiveness of Perioperative Immune Checkpoint Therapy for NSCLC in Japan, the United States, and BrazilMasahiro Fujioka, Toshihiko Aranishi, Takehito Shukuya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2020
Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLCTakehito Shukuya, Vikas Ghai, Joseph M Amann, et al.
Clinical Lung Cancer|July 10, 2018
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung CancerAshwini Arunachalam, Haojie Li, Marisa A Bittoni, et al.
European Journal of Cancer|January 1, 1977
Phase I-II trial of intramuscularly administered bleomycinM H Cohen, S J Pocock, E D Savlov, et al.
Journal of the National Cancer Institute|December 15, 1993
Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survivalS F Winter, Y Sekido, J D Minna, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2019
The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung CancerTakehito Shukuya, Tadaaki Yamada, Michael J Koenig, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2018
Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLCSara L Sinicropi-Yao, Joseph M Amann, David Lopez Y Lopez, et al.
Pageof 66